
    
      This study will evaluate the topical SHR0302 ointment, a JAK (Janus Kinase) inhibitor, in
      atopic dermatitis patients. The EASI (Eczema Area and Severity Index), IGA (immunoglobulin
      A), SCORAD (Scoring of Atopic Dermatitis),DLQI (Dermatology Life Quality Index)and NRS
      (Numeric Rating Score) will be applied to assesses to the efficacy, and other safety
      measurements will be also collected within the whole study duration.
    
  